Home infusion can lower costs and improve access, but requires complex coordination, patient readiness, logistics, and monitoring to ensure safe and effective care.
- Blind Spots And Blocked Ports: Surviving Clinical Supply Friction In LATAM And APAC
- Truth: Clinical Supply Is Often The First To See The Whole Picture
- The $122 Billion Question: Can Clinical Trial Supply Systems Keep Pace With Cell Therapy Demand?
- From Individual Shipments To Patterns: How Compliance Is Understood Over Time
- Geopolitical Risk Is Reshaping Clinical Trial Supply Chains
- How Real-World, Real-Time, And Synthetic Data Are Revolutionizing Clinical Trial Supply Chains
- The Atlantic Divide: Forcing FDA Demographics Onto European Supply Chains
- Expanding Clinical Trials In Africa Without Disruption
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Analytics–Powered Approach To Patient Recruitment Strategy
In a Phase 3 psychiatry trial, a pharmaceutical company partnered with Signant to revolutionize patient recruitment through data-driven site selection using PureSignal Analytics.
-
The Dual Sourcing Approach
Having a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines should be an essential part of your strategy in terms of patient health.
-
Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions
Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.
-
IRT? RTSM? What's The Difference?
What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?
-
Effective Use Of IRT In Decentralized And Hybrid Clinical Trials
Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.
-
5 Ways To Get Ready For IRT Regulatory Inspections
Preparing for a regulatory inspection during a clinical trial can be daunting. Learn about the importance of clear roles, audit trails, data integrity, and training, and get recommendations to help.
-
Developmental Testing Of IV Solutions
As IV-administered drugs proliferate, sponsors must understand the associated regulatory requirements, methodologies for useful/required information, and formulations suitable for administration.
-
Emerging Biopharm Rapidly Sets Up Phase 1 Oncology Trial
Uncover how an emerging biopharmaceutical company was able to expedite the initiation of a Phase 1 oncology trial for a novel treatment targeting relapsed/refractory multiple myeloma.
-
A Practical Packaging Components Checklist For Emerging Biotechs
A proactive approach to packaging development can ultimately ensure a smoother launch. Explore five key considerations when selecting components for your injectable drug product.
-
GMP Clinical Storage Solutions for Today's Complex Trials
How material traits, dosing approaches, and equipment design affect capsule‑filling accuracy and efficiency, giving teams insight to improve dose precision and support small‑scale manufacturing.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.